Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia

Summary

The purpose of this study is to evaluate the efficacy of changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5%) from prior prostaglandin analogue or beta-blocker monotherapy in Russian glaucoma patients with open-angle glaucoma or ocular hypertension whose intraocular pressure (IOP) is uncontrolled while on their current treatment.

Timeline

Start

2013-02

Primary completion

2013-02

Completion

2013-02

Drugs

Indications